POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (5.13.2021, 12:396pm CEST, WHO):   U.S. 36,412    India 362,727    Brazil 72,715    France 18,323    Turkey 14,497    Russia 8,115    The United Kingdom 2,474    Italy 6,943    Spain 2,768    Germany 14,909    Argentina 25,976    Columbia 16,425    Poland 4,159    Iran 16,409    Mexico 1,897    Ukraine 4,538    Peru 4,869    Indonesia 4,608    Czechia 1,686    South Africa 2,759    The Netherlands 5,586    Canada 5,386    Chile 3,902    Iraq 4,666    Philippines 4,812    Romania 1,156    Sweden 2,463    Pakistan 2,881    Bangladesh 1,140    Serbia 1,125    Japan 6,927    United Arab Emirates 1,508    Malaysia 4,765    Saudi Arabia 1,020    Nepal 9,238    Greece 3,172    Croatia 1,471    Georgia 1,409    Tunisia 1,105    Bolivia 2,369    Paraguay 2,377    Costa Rica 2,236    Lithuania 1,266    Egypt 1,187    Guatemala 1,416    Uruguay 2,977    Honduras 1,130    Bahrain 1,539    Sri Lanka 1,429    Cuba 1,207    Thailand 14,887    Maldives 1,572    China 32    Singapore 16    New Zealand 1    Australia 8    South Korea 715   

Several U.S. states shut down Johnson & Johnson vaccine sites after adverse reactions reported

Christian Fernsby |
Several states in the United States have temporarily shut down some vaccine sites after people suffered adverse reactions to the shot.

Article continues below




A total of 18 people in North Carolina reported side effects, while 11 people in Colorado reacted to the shot with symptoms ranging from dizziness, nausea and fainting, according to media reports.

Georgia was the third U.S. state to temporarily shut down a vaccine site following North Carolina and Colorado, after eight people suffered adverse reactions following vaccination.

According to local officials, one person was sent to a nearby hospital for evaluation before being released. The other seven were sent home after being monitored at the site.

The U.S. Centers for Disease Control and Prevention (CDC) said its analysis "did not find any safety issues or reason for concern." The agency recommended that healthcare providers continue to administer the Johnson & Johnson vaccine.

Another problem facing Johnson & Johnson is vaccine distribution. The supply of Johnson & Johnson's COVID-19 vaccine is expected to drop by 85 percent nationwide this week, after the company suffered production issues at a facility in Baltimore, Maryland, according to federal officials and data.

A manufacturing subcontractor in Baltimore mixed ingredients from the COVID-19 vaccines of Johnson & Johnson and AstraZeneca, delaying shipments of the Johnson & Johnson shot across the nation.

The plant is run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca. Federal officials attributed the mistake to human error, which resulted in contamination of up to 15 million doses of Johnson & Johnson's vaccine.

Jeff Zients, the White House coronavirus coordinator, said Friday that the company is still working to address the production issues in Emergent BioSolutions, which is not certified yet by the U.S. Food and Drug Administration (FDA).

Johnson & Johnson's COVID-19 vaccine was approved for emergency use in the United States in late February. It is the third COVID-19 vaccine that has received FDA's authorization, also the first single dose COVID-19 vaccine available in the United States.

As of Monday, about 189 million COVID-19 vaccine shots have been administered, while more than 237 million COVID-19 vaccine doses have been distributed across the country, according to data of the CDC.


What to read next

New vaccine to provide 2-year protection
Moderna begins testing next-generation coronavirus vaccine
Johnson & Johnson says its single-dose COVID-19 vaccine is 66% effective